Recent regulatory approvals and pivotal clinical results represent important milestones in the long term safety and efficacy of microbiome-based therapies.
With over 50 new clinical trials initiated in the past 12 months, and new research programs leveraging novel microbiome-based technologies and biomarkers, access the insight you need to make better microbiome-based drug development decisions.
Translating Innovative Microbiome Research into Safe & Effective Products
The Microbiome Movement’s mission is to provide the industry with unparalleled insights into the latest drug development milestones at a time where recent approvals and clinical achievements are stimulating renewed excitement and investment, this insight has never been more critical.
Through qualified and granular insights that bring clarity to the complexity of causal microbiome research, the Microbiome Movement provides access to the latest information drug developers need to accelerate their pipelines. Moreover, the industry-leading events offer anyone working in the microbiome space – across different modalities, microbiome types and disease areas – the opportunity to exchange experiences with drug developers who are committed to discovering, translating, and clinically demonstrating the power of the microbiome into effective and commercially successful products.
Featured Microbiome Products
Microbiome Movement -Maternal & Infant Health
8th Microbiome Mvmt – Drug Development Summit
6th Microbiome Mvmt – Skin Health & Dermatology
Microbiome Products by Type
Premium Insight and Meaningful Connections for Biopharma
Make Faster, Better Drug Development Decisions
Premium Insight, Collaborative Learning & Mission-Focused Connections for Biopharma
Get in touch
We speak to hundreds of biopharmaceutical experts from industry and academia every day. We would love for you to be one of them. Contact us to discover how our events can accelerate your drug development.
Standard Form - Microbiome
"*" indicates required fields